B
CRMD icon

Bailard’s CorMedix CRMD Stock Holding History

Bailard’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Buy
+15,500
New +$122K ﹤0.01% 754
2026
Q1 		– Sell
-12,200
Closed -$142K – 759
2025
Q4 		$142K Buy
+12,200
New +$135K ﹤0.01% 728

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bailard's CRMD Position: Q2 2026 in Review

Bailard opened a new position in CorMedix (CRMD) in Q2 2026: 15,500 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #754 among its holdings. This is a return to the name: Bailard previously reported a position in CRMD as recently as Q4 2025.

Bailard first reported a position in CRMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $142K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Bailard held 15,500 shares of CorMedix worth $122K as of Q2 2026.
  • CorMedix was a new Bailard position in Q2 2026.
  • CorMedix made up ﹤0.01% of Bailard's portfolio in Q2 2026, its #754 holding.
  • Bailard first reported a position in CorMedix in Q4 2025 and has held it in 2 quarters since.
  • Bailard's CorMedix position peaked at $142K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.